|
|
Volumn 17, Issue 1, 1998, Pages 41-47
|
|
Pediatric scleroderma
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIMALARIAL AGENT;
BIOLOGICAL MARKER;
CIMETIDINE;
CORTICOSTEROID;
CYCLOSPORIN;
DEFLAZACORT;
IMMUNOGLOBULIN;
INTERLEUKIN 2 RECEPTOR;
KETOTIFEN;
METHOTREXATE;
PENICILLAMINE;
PREDNISONE;
PSORALEN DERIVATIVE;
BLOOD TOXICITY;
CHILD;
CHILDHOOD DISEASE;
CLINICAL FEATURE;
CONSERVATIVE TREATMENT;
DIFFERENTIAL DIAGNOSIS;
DISEASE ACTIVITY;
DISEASE COURSE;
GROWTH DISORDER;
HUMAN;
IMMUNOTOXICITY;
INCIDENCE;
INFECTION;
LIVER TOXICITY;
NEPHROTOXICITY;
NUCLEAR MAGNETIC RESONANCE IMAGING;
ORAL DRUG ADMINISTRATION;
OSTEOPOROSIS;
PHOTODYNAMIC THERAPY;
PROGNOSIS;
REVIEW;
SCLERODERMA;
SOCIAL PSYCHOLOGY;
STEROID THERAPY;
TOPICAL DRUG ADMINISTRATION;
ADOLESCENT;
ADULT;
AGE OF ONSET;
CHILD;
CHILD, PRESCHOOL;
DIAGNOSIS, DIFFERENTIAL;
FEMALE;
HUMANS;
INCIDENCE;
MALE;
PROGNOSIS;
SCLERODERMA, LOCALIZED;
SCLERODERMA, SYSTEMIC;
|
|
EID: 0031930798
PISSN: 10855629
EISSN: None
Source Type: Journal
DOI: 10.1016/S1085-5629(98)80061-8 Document Type: Review |
|
Times cited : (34)
|
|
References (28)
|
